Skip to content
healthcare.dev

Liraglutide

NDC 0480-3667, liraglutide, injection, from Teva Pharmaceuticals USA, Inc..

Product NDC
0480-3667
Status
Listed
Labeler
Teva Pharmaceuticals USA, Inc.
Dosage form
INJECTION
Route
SUBCUTANEOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA AUTHORIZED GENERIC
Application
NDA022341
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0480-3667 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • LIRAGLUTIDE6 mg/mL

Pharmacologic classes

GLP-1 Receptor Agonist [EPC]; Glucagon-Like Peptide 1 [CS]; Glucagon-like Peptide-1 (GLP-1) Agonists [MoA]

Package NDCNDC-11Package
0480-3667-20004803667202 SYRINGE, PLASTIC in 1 CARTON (0480-3667-20) / 3 mL in 1 SYRINGE, PLASTIC (0480-3667-19)
0480-3667-22004803667223 SYRINGE, PLASTIC in 1 CARTON (0480-3667-22) / 3 mL in 1 SYRINGE, PLASTIC (0480-3667-19)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/14bf9812-14ee-46ce-93b1-686e4906cbbc
  • NADAC price for package 00480366720

    GET /v1/drugs/nadac/00480366720
  • NADAC price for package 00480366722

    GET /v1/drugs/nadac/00480366722

Use it

Look up 0480-3667 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0480-3667 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0480-3667. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.